Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically engineered mice and cell lines containing alterations in the genes encoding retinoic acid receptor and retinoid X receptor proteins

Genetically engineered mice and cell lines containing alterations in the genes encoding retinoic acid receptor and retinoid X receptor proteins

US Patent 6030794 · Granted Feb 29, 2000

Estimated economic value: $256,900,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Branched polymers2025
Non-steroidal selective glucocorticoid receptor agonistic modulators (SEGRAMs) a2021
Method for controlling the biological activity of a protein in a vertebrate cell2016
Method of effecting de-differentiation of a cell2015
Transgenic mouse for targeted recombination mediated by modified Cre-ER2006
Method for the stable inversion of DNA sequence by site-specific recombination a2006
Transcriptional intermediary factor-22005
Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments codi2004
Therapeutic combinations of RAR antagonists and RXR agonists and use thereof2003
Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof2003
Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof2003
Transgenic animal whose expression of the opiate receptors is modified2003